Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
about
Clinical utility of RapidArc™ radiotherapy technology.New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomasConsensus report of the 2015 Weinman International Conference on MesotheliomaModern management of malignant pleural mesotheliomaSurgical treatment of malignant pleural mesothelioma.[Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy].Volumetric modulated arc therapy: a review of current literature and clinical use in practice.Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.Investigational approaches for mesothelioma.Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model.First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy.Perspective on malignant pleural mesothelioma diagnosis and treatmentDo we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC databaseRadical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgeryIdentification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring.Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.Surgery for malignant pleural mesothelioma.Malignant pleural mesothelioma: when is radiation therapy indicated?Summary of prognostic factors and patient selection for extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma.Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.Systemic treatment of malignant pleural mesothelioma.Systematic review of trimodality therapy for patients with malignant pleural mesothelioma.Surgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies.Management of malignant pleural mesothelioma-The European experience.Local and systemic therapies for malignant pleural mesothelioma.The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence.Current surgical strategies for malignant pleural mesothelioma.Advances in treatment of mesothelioma.Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations.Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma.Safety and efficacy of trimodality therapy in patients undergoing extrapleural pneumonectomy.Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?
P2860
Q26773193-F93AB17F-6A59-418D-8F0F-91DD965A3B01Q26859274-95E0C288-09E5-484D-BC7C-349EA083414EQ27908468-6783BF91-5C36-494F-ABBD-A7580E149E4AQ29248127-0E15D7C5-87C0-470E-8831-79A6A54787BBQ30401535-1A288E63-DE1A-4721-913D-2F52F2DA9C6AQ30429528-62155741-958D-4E7E-8EE8-BB91F67ABA46Q30461426-8550C97B-C9C0-4920-9896-1ED102C5ECC5Q33390765-54CEB2E5-2B81-421F-8D09-9E42037F0C11Q33414357-F9980EA9-AD52-4224-B633-027ADD3B85E1Q34293068-C020161D-D81E-40E3-8BEA-7F8A917F627CQ35141809-000E5C56-58FB-4CCD-A778-30D40CB9E3E7Q35182037-BCDFFC67-0129-4F8B-800A-5DA456640EEBQ35828606-837AB4C4-8A22-4DF2-88A9-CA1595BFE02BQ35832320-6A76AA0C-D254-4888-85B7-6D741524E7D0Q36345736-310B6BA4-1E29-4D7B-9929-DC980E0EDE2FQ36790055-3E37C984-A739-4BDA-8132-8AE851263DF2Q37090784-10E008BD-3A6E-4CF1-A0D8-6B48BA94ECDFQ37090803-912DA2EB-B768-49E6-8617-E4E46A5133EBQ37090812-48661A56-85E0-42FB-A2C2-F8E2FCD37F92Q37307952-273F2A8D-6102-4354-B68B-A3A6638BD9AEQ37368672-136C0E7E-8461-407C-A7A1-5C0C78050527Q37762833-41E6F8BA-7B7C-4B14-A05F-5AB84CD25507Q37866786-37B2FCF9-1690-426B-B1D6-E8DDE2A7658BQ37867989-9643F017-65B4-458C-B2C1-ADE48D75B1FBQ37975136-7EC13E44-D25E-4A5D-96F5-EA7FFA526B38Q37992694-5C54C459-D491-451B-A8AD-B79238BBDF42Q38131498-452C0DA4-F5E2-41EB-9811-3375AAD55119Q38195607-902DF6C4-960A-48EF-A6E8-6C187882CE96Q38215513-F1AC6DDC-7727-405B-800B-445BE6DC00DEQ38255347-A519C991-5A09-4EE4-A2D8-7973EAA143C0Q38438794-AA0F4FEE-A21E-4394-8531-F78B77E63084Q38641574-A2F93F3B-5A91-431C-8F39-A3F37AF34CEEQ38800916-88701E92-85FC-4F11-AB67-CF7D5D00D199Q38843154-E0C7F125-B467-46A6-B215-074A5E2CC27DQ38870822-5560074D-1BD4-467F-9A4D-7B9C9BD8AFF6Q39260316-6691D82D-16FF-4464-9082-6E4A42518DD9Q39350596-93F0E70D-B4E9-4EB5-8A71-766DEF6261D4Q39860551-15870188-7994-4A1C-8060-DB2379F8149AQ40688498-31D50123-73D6-4364-A052-BC666995BE0AQ40964772-F861A2CA-D623-458C-A5BB-DB844435C7DB
P2860
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@en
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@nl
type
label
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@en
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@nl
prefLabel
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@en
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@nl
P2093
P921
P356
P1476
Trimodality therapy with induc ...... alignant pleural mesothelioma.
@en
P2093
Andrea Bezjak
B C John Cho
Heidi Roberts
Masaki Anraku
Michael R Johnston
Natasha Leighl
Ronald Burkes
Ronald Feld
Shaf Keshavjee
P304
P356
10.1200/JCO.2008.17.5604
P407
P577
2009-02-17T00:00:00Z